San Diego, CA, United States of America

Garth A Kinberger

This inventor holds 12 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Ionis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc., Astrazeneca Ab. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Garth A Kinberger. Retrieved from https://idiyas.com/inventor/garth-a-kinberger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 163(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Journey of Garth A Kinberger

Introduction: Garth A Kinberger is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Garth A Kinberger holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Garth A Kinberger has worked with leading companies to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Garth A Kinberger has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life, resulting in successful products and technologies.

Conclusion: Garth A Kinberger's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…